Special Feature
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Alexander Fleming
PMI Ciência: Mitos, Histórias e Factos A. Fleming Referência: http://www.time.com/time/time100/scientist/profile/fleming.html Alexander Fleming A spore that drifted into his lab and took root on a culture dish started a chain of events that altered forever the treatment of bacterial infections By DR. DAVID HO The improbable chain of events that led Alexander bacteriologist." Although he went on to perform Fleming to discover penicillin in 1928 is the stuff of additional experiments, he never conducted the one which scientific myths are made. Fleming, a young that would have been key: injecting penicillin into Scottish research scientist with a profitable side infected mice. Fleming's initial work was reported in practice treating the syphilis infections of prominent 1929 in the British Journal of Experimental Pathology, London artists, was pursuing his pet theory — that his but it would remain in relative obscurity for a decade. own nasal mucus had antibacterial effects — when he By 1932, Fleming had abandoned his work on left a culture plate smeared with Staphylococcus penicillin. He would have no further role in the bacteria on his lab bench while he went on a two-week subsequent development of this or any other antibiotic, holiday. aside from happily providing other researchers with When he returned, he noticed a clear halo surrounding samples of his mold. It is said that he lacked both the the yellow-green growth of a mold that had chemical expertise to purify penicillin and the accidentally contaminated the plate. Unknown to him, conviction that drugs could cure serious infections. -
Curing Childhood Leukemia, October 1997
This article was published in 1997 and has not been updated or revised. CURING CHILDHOOD LEUKEMIA ancer is an insidious disease. The culprit is not bacterial infections, viral infections, and many other a foreign invader, but the altered descendants illnesses. _) of our own cells, which reproduce uncontrol The fight against cancer has been more of a war of lably. In this civil war, it is hard to distinguish friend attrition than a series of spectacular, instantaneous vic from foe, to tat;get the cancer cells without killing the tories, and the research into childhood leukemia over the healthy cells. Most of our current cancer therapies, last 40 years is no exception. But most of the children who including the cure for childhood leukemia described here, are victims of this disease can now be cured, and the are based on the fact that cancer cells reproduce without drugs that made this possible are the antimetabolite some of the safeguards present in normal cells. If we can drugs that will be described here. The logic behind those interfere with cell reproduction, the cancer cells will be drugs came from a wide array of research that defined hit disproportionately hard and often will not recover. the chemical workings of the cell--research done by scien The scientists and physicians who devised the cure for tists who could not know that their findings would even childhood leukemia pioneered a rational approach to tually save the lives of up to thirty thousand children in destroying cancer cells, using knowledge about the cell the United States. -
Arsinothricin, an Arsenic-Containing Non-Proteinogenic Amino Acid Analog of Glutamate, Is a Broad-Spectrum Antibiotic
ARTICLE https://doi.org/10.1038/s42003-019-0365-y OPEN Arsinothricin, an arsenic-containing non-proteinogenic amino acid analog of glutamate, is a broad-spectrum antibiotic Venkadesh Sarkarai Nadar1,7, Jian Chen1,7, Dharmendra S. Dheeman 1,6,7, Adriana Emilce Galván1,2, 1234567890():,; Kunie Yoshinaga-Sakurai1, Palani Kandavelu3, Banumathi Sankaran4, Masato Kuramata5, Satoru Ishikawa5, Barry P. Rosen1 & Masafumi Yoshinaga1 The emergence and spread of antimicrobial resistance highlights the urgent need for new antibiotics. Organoarsenicals have been used as antimicrobials since Paul Ehrlich’s salvarsan. Recently a soil bacterium was shown to produce the organoarsenical arsinothricin. We demonstrate that arsinothricin, a non-proteinogenic analog of glutamate that inhibits gluta- mine synthetase, is an effective broad-spectrum antibiotic against both Gram-positive and Gram-negative bacteria, suggesting that bacteria have evolved the ability to utilize the per- vasive environmental toxic metalloid arsenic to produce a potent antimicrobial. With every new antibiotic, resistance inevitably arises. The arsN1 gene, widely distributed in bacterial arsenic resistance (ars) operons, selectively confers resistance to arsinothricin by acetylation of the α-amino group. Crystal structures of ArsN1 N-acetyltransferase, with or without arsinothricin, shed light on the mechanism of its substrate selectivity. These findings have the potential for development of a new class of organoarsenical antimicrobials and ArsN1 inhibitors. 1 Department of Cellular Biology and Pharmacology, Florida International University, Herbert Wertheim College of Medicine, Miami, FL 33199, USA. 2 Planta Piloto de Procesos Industriales Microbiológicos (PROIMI-CONICET), Tucumán T4001MVB, Argentina. 3 SER-CAT and Department of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA. -
Multi-Residue Determination of Organic Arsenical Drugs in Feeds by LC-MS/MS
Multi-Residue Determination of Organic Arsenical Drugs in Feeds by LC-MS/MS Geneviève Grenier, Melanie Titley & Lise-Anne Prescott AAFCO Laboratory Methods and Services Committee meeting 2016-01-18 Background • Animal Feed Division of CFIA identified a high priority need for the determination of three organic arsenicals (arsanilic acid, roxarsone and nitarsone) at residue levels in animal feed • These are withdrawal drugs and are priority food contaminants • Current test methods are at guarantee levels greater than 10% minimum use rate • Therefore, current methods not well suited for residue or traceback testing • Requested feed residue LOQ of 1 mg/kg for all three organic arsenicals 2 Background • UHPLC-PDA Challenges • Extract were very dirty • Tried sample clean-up using Oasis MAX SPE • Still very dirty • HPLC Challenges • Compounds elute too easily • Analytical column must : retain and separate compounds, and give good peak shape • Analytical column : Phenomenex Onyx Monolithic C18 100 X 3.0mm 3 Background • LC/MS/MS method (positive mode) • Column: Phenomenex Onyx Monolithic C18 100 X 3.0mm • Linearity problems with Internal Standard (IS) • Internal standard – 4-hydroxyphenylarsonic acid • Peak area of the internal standard increased with increasing analyte concentration • Cause • 4-hydroxyphenyl arsanic acid co-elute with Arsanilic acid and have similar m/z 4 New method - summary • Liquid chromatography combined with atomic and molecular mass spectrometry for speciation of arsenic in chicken liver. Peng et. al., Journal of Chromatography -
The Nobel Prize for Physiology and Medicine
The Nobel Prize for Physiology or Medicine Some history The inscription reads “Inventas vitam juvat excoluisse per artes” (inventions enhance life which is beautified through art.), or, loosely translated, "they who bettered life on earth by their newly found mastery." History of the Nobel Prize for Physiology or Medicine • At his death Alfred Nobel bequeathed some kr32 million (Kronor) to the prize fund (the 2014 equivalent of kr1,702,000,000 [$194,449,755]. As of 2011, the foundation reported assets of Kr2,968,547,000 ($339,149,964) • The original prize in 1901 was valued at kr150,782, equivalent to kr8,178,781 in 2014 ($933,082). The prize in 2014 was valued at Value of prize relaive to 1901 kr8,000,000 ($ 912,686). 160 140 120 The amount of the prize has varied considerably: 100 80 it has been as low as kr2,269,498 (1919) and as Percent 60 40 high as kr11,737,705 (2001) 20 0 1901 1908 1915 1922 1929 1936 1943 1950 1957 1964 1971 1978 1985 1992 1999 2006 2013 Years History of the Nobel Prize for Physiology or Medicine • As described in Nobel's will, one prize was to be dedicated to "the person who shall have made the most important discovery within the domain of physiology or medicine". • 105 Nobel Prizes in Physiology or Medicine have been awarded since 1901 to a total of 207 recipients. • None were awarded during the war years of 1915-1918 and 1940-1942. • None were awarded in 1921 and 1925. The statutes of the Nobel Foundation say that: "If none of the works under consideration is found to be of the importance indicated in the first paragraph, the prize money shall be reserved until the following year. -
National Center for Toxicological Research (NCTR) Science Advisory Board (SAB)
National Center for Toxicological Research (NCTR) Science Advisory Board (SAB) November 2, 2016 Crowne Plaza 201 S. Shackleford Road Little Rock, AR 72211 TABLE OF CONTENTS FDA Center Perspectives 1 Center for Biologics Evaluation and Research Center for Drug Evaluation and Research Center for Devices and Radiological Health Center for Tobacco Products Center for Veterinary Medicine Office of Regulatory Affairs Discussion of NCTR Research (SAB Members) 120 1 P R O C E E D I N G S Agenda Item: FDA Center Perspectives DR. PHILBERT: Good morning. Our first presentation in a series from our colleagues at FDA is from Carolyn, Center for Biologics Evaluation and Research. DR. WILSON: Good morning. Thank you. I am going to start with an overview of the products we regulate just to orient some of you who may be new on the advisory board. Then I will go into the priorities for our scientific research program, as well as some examples of ongoing and potential future collaborations with NCTR. We regulate what are called complex biologic products, so things like monoclonal antibodies and most recombinant proteins are regulated in the Center for Drugs. But we regulate things like blood, blood components and derivatives, vaccines both preventative and therapeutic, the novel areas like cell and gene therapies, including stem cells, and that does include things like CRISPR modification of cells. Certain human tissues, live biotherapeutics and, yes, that includes fetal transplantation, allergenic products which actually, although that is a single line, represents over 1200 different extracts that are used both for diagnosis 2 and treatment of allergies, and then certain related devices, as well. -
Gerhard Domagk – Biography
Gerhard Domagk – Biography The Nobel Prize in Physiology or Gerhard Johannes Paul Domagk was born on Medicine 1939 October 30, 1895, at Lagow, a beautiful, small town Presentation Speech in the Brandenburg Marches. Until he was fourteen he went to school in Sommerfeld, where his father Gerhard Domagk Biography was assistant headmaster. His mother, Martha Nobel Lecture Reimer, came from farming stock in the Marches, where she lived in Sommerfeld until 1945 when she was expelled from her home; she died from 1938 1940 starvation in a refugee camp. The 1939 Prize in: Domagk himself was, from the age of 14, at school Physics in Silesia until he reached the upper sixth form. He Chemistry Physiology or Medicine then became a medical student at Kiel and, when Literature the 1914-1918 War broke out, he served in the Army, and in December Peace 1914 was wounded. Later he was sent to join the Sanitary Service and Find a Laureate: served in, among other places, the cholera hospitals in Russia. During this time he was decisively impressed by the helplessness of the medical men Name of that time when they were faced with cholera, typhus, diarrhoeal infections and other infectious diseases. He was especially strongly influenced by the fact that surgery had little value in the treatment of these diseases and even amputations and other forms of radical treatment were often followed by severe bacterial infections, such as gas gangrene. In 1918 he resumed his medical studies at Kiel and in 1921 he took his State Medical Examinations and graduated. He undertook laboratory work under Max Bürger on creatin and creatinin, and later metabolic studies and analysis under Professors Hoppe-Seyler and Emmerich. -
Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals
Florida International University FIU Digital Commons FIU Electronic Theses and Dissertations University Graduate School 11-13-2020 Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals Luis D. Garbinski Florida International University, [email protected] Follow this and additional works at: https://digitalcommons.fiu.edu/etd Part of the Biochemistry Commons, Environmental Microbiology and Microbial Ecology Commons, and the Molecular Biology Commons Recommended Citation Garbinski, Luis D., "Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals" (2020). FIU Electronic Theses and Dissertations. 4549. https://digitalcommons.fiu.edu/etd/4549 This work is brought to you for free and open access by the University Graduate School at FIU Digital Commons. It has been accepted for inclusion in FIU Electronic Theses and Dissertations by an authorized administrator of FIU Digital Commons. For more information, please contact [email protected]. FLORIDA INTERNATIONAL UNIVERSITY Miami, Florida BACTERIAL MECHANISMS OF TOXICITY AND RESISTANCE TO ORGANOARSENICALS A dissertation submitted in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY in BIOMEDICAL SCIENCES by Luis D Garbinski 2020 To: Dean Robert Sackstein Herbert Wertheim College of Medicine This dissertation, written by Luis D Garbinski, and entitled Bacterial Mechanisms of Toxicity and Resistance to Organoarsenicals, having been approved in respect to style and intellectual content, is referred to you for judgement. We have read this dissertation and recommend that it be approved. _______________________________________ Irina Agoulnik _______________________________________ Jun-yong Choe _______________________________________ Krishnaswamy Jayachandran _______________________________________ Masafumi Yoshinaga, Co-Major Professor _______________________________________ Barry Rosen, Co-Major Professor Date of Defense: November 11, 2020 The dissertation of Luis D Garbinski is approved. -
Photooxidation of P-Arsanilic Acid in Aqueous Solution by UV/Persulfate Process
applied sciences Communication Photooxidation of p-Arsanilic Acid in Aqueous Solution by UV/Persulfate Process Xiangyi Shen 1, Jing Xu 2,*, Ivan P. Pozdnyakov 3,4 and Zizheng Liu 5,* ID 1 Department of Environmental Science, School of Resource and Environmental Sciences, Wuhan University, Wuhan 430079, China; [email protected] 2 State Key Laboratory of Water Resources and Hydropower Engineering Science, Wuhan University, Wuhan 430072, China 3 Institute of Chemical Kinetics and Combustion, Institutskaya 3, 630090 Novosibirsk, Russia; [email protected] 4 Novosibirsk State University, Pirogova str. 2, 630090 Novosibirsk, Russia 5 School of Civil Engineering, Wuhan University, Wuhan 430072, China * Correspondence: [email protected] (J.X.); [email protected] (Z.L.) Received: 26 February 2018; Accepted: 4 April 2018; Published: 13 April 2018 Abstract: Used as a kind of feed additive, p-arsanilic acid can pose a potential risk to organisms when abandoned in the environment. The photodegradation of p-ASA was investigated under UV-C irradiation in the presence of persulfate (PS) in this work. The addition of PS facilitated the decomposition of p-ASA and notably, the presence of 50 mmol PS brought about a nearly complete mineralization after 3 h, while an insignificant total organic carbon (TOC) removal was observed − under UV irradiation (λ = 254 nm) only. Experimental results proved that sulfate radical (SO4• ) was responsible for the promotion effect. The cleavage of As-C bond released inorganic arsenic and caused the occurrence of various organic products, for example, hydroxybenzaldehyde, nitrobenzene, benzenediol sulfate, and biphenylarsinic acid. The application of PS with UV-C light may throw a light on thorough treatment for p-ASA containing wastewater. -
Transformation of Para Arsanilic Acid by Manganese Oxide: Adsorption, Oxidation, and Influencing Factors
Water Research 116 (2017) 126e134 Contents lists available at ScienceDirect Water Research journal homepage: www.elsevier.com/locate/watres Transformation of para arsanilic acid by manganese oxide: Adsorption, oxidation, and influencing factors * Tista Prasai Joshi a, c, Gong Zhang b, Hanyang Cheng a, c, Ruiping Liu a, c, , Huijuan Liu b, c, Jiuhui Qu a, c a Key Laboratory of Drinking Water Science and Technology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China b State Key Laboratory of Environmental Aquatic Chemistry, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences, Beijing 100085, China c University of Chinese Academy of Sciences, Beijing 100049, China article info abstract Article history: Aromatic organoarsenic compounds tend to transform into more mobile toxic inorganic arsenic via Received 19 December 2016 several processes, and can inadvertently spread toxic inorganic arsenic through the environment to Received in revised form water sources. To gain insight into the transformation mechanisms, we herein investigated how the 8 March 2017 process of para arsanilic acid (p-ASA) transformation works in detail on the surface of adsorbents by Accepted 11 March 2017 comparing it with phenylarsonic acid (PA) and aniline, which have similar chemical structures. In Available online 18 March 2017 À À contrast to the values of 0.23 mmol g 1 and 0.68 mmol g 1 for PA and aniline, the maximum adsorption À capacity was determined to be 0.40 mmol g 1 for p-ASA at pH 4.0. The results of FTIR and XPS spectra Keywords: Para arsanilic acid supported the presence of a protonated amine, resulting in a suitable condition for the oxidation of p- fi Phenylarsonic acid ASA. -
Nobel Laureates in Physiology Or Medicine
All Nobel Laureates in Physiology or Medicine 1901 Emil A. von Behring Germany ”for his work on serum therapy, especially its application against diphtheria, by which he has opened a new road in the domain of medical science and thereby placed in the hands of the physician a victorious weapon against illness and deaths” 1902 Sir Ronald Ross Great Britain ”for his work on malaria, by which he has shown how it enters the organism and thereby has laid the foundation for successful research on this disease and methods of combating it” 1903 Niels R. Finsen Denmark ”in recognition of his contribution to the treatment of diseases, especially lupus vulgaris, with concentrated light radiation, whereby he has opened a new avenue for medical science” 1904 Ivan P. Pavlov Russia ”in recognition of his work on the physiology of digestion, through which knowledge on vital aspects of the subject has been transformed and enlarged” 1905 Robert Koch Germany ”for his investigations and discoveries in relation to tuberculosis” 1906 Camillo Golgi Italy "in recognition of their work on the structure of the nervous system" Santiago Ramon y Cajal Spain 1907 Charles L. A. Laveran France "in recognition of his work on the role played by protozoa in causing diseases" 1908 Paul Ehrlich Germany "in recognition of their work on immunity" Elie Metchniko France 1909 Emil Theodor Kocher Switzerland "for his work on the physiology, pathology and surgery of the thyroid gland" 1910 Albrecht Kossel Germany "in recognition of the contributions to our knowledge of cell chemistry made through his work on proteins, including the nucleic substances" 1911 Allvar Gullstrand Sweden "for his work on the dioptrics of the eye" 1912 Alexis Carrel France "in recognition of his work on vascular suture and the transplantation of blood vessels and organs" 1913 Charles R. -
Antimcrobial Stewardship 11-11
11/8/11 Antimicrobial Stewardship Protecting a Valuable Resource November 8, 2011 Edward Lifshitz, MD Medical Director Communicable Disease Service NJDHSS [email protected] (609) 826-5964 Edward Lifshitz, MD [email protected] “One can think of the middle of the twentieth century as the end of one of the most important social revolutions in history, the virtual elimination of infectious diseases as a significant factor in social life” 1962 Sir Frank MacFarlane Burnet Director of the Walter and Eliza Hall Institute of Medical Research 1960 Nobel Prize co-winner in Physiology or Medicine Edward Lifshitz, MD [email protected] “Unless we act to protect these medical miracles, we could be heading for a post-antibiotic age” 2001 Gro Harlem Brundtland WHO Director-General Edward Lifshitz, MD [email protected] 1 11/8/11 Antimicrobial Stewardship “Antimicrobial stewardship programs in hospitals seek to optimize antimicrobial prescribing in order to improve individual patient care as well as reduce hospital costs and slow the spread of antimicrobial resistance.” Clinical Microbiology Reviews, October 2005, p. 638-656, Vol. 18, No. 4 Edward Lifshitz, MD [email protected] Microbes vs Humans Microbes Microbes Humans by factor # on Earth 5 x 1031 7 x 109 ~ 1022 # cells in a Human 5 x 1013 5 x 1012 ~ 5 - 10 Mass - kg 5 x 1019 3 x 1011 ~ 108 Generation time 30 min 30 years ~ 5 x 105 Time on earth, years 3.5 x 109 4 x 106 ~ 103 Data: Schaechter M, et al, Microbiology in the 21st century: